These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 16246085

  • 1. Membrane raft lipid constituents affect drug susceptibilities of Candida albicans.
    Pasrija R, Prasad T, Prasad R.
    Biochem Soc Trans; 2005 Nov; 33(Pt 5):1219-23. PubMed ID: 16246085
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Morphogenic regulator EFG1 affects the drug susceptibilities of pathogenic Candida albicans.
    Prasad T, Hameed S, Manoharlal R, Biswas S, Mukhopadhyay CK, Goswami SK, Prasad R.
    FEMS Yeast Res; 2010 Aug 01; 10(5):587-96. PubMed ID: 20491944
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Multidrug transporters CaCdr1p and CaMdr1p of Candida albicans display different lipid specificities: both ergosterol and sphingolipids are essential for targeting of CaCdr1p to membrane rafts.
    Pasrija R, Panwar SL, Prasad R.
    Antimicrob Agents Chemother; 2008 Feb 01; 52(2):694-704. PubMed ID: 18056285
    [Abstract] [Full Text] [Related]

  • 9. Serum repressing efflux pump CDR1 in Candida albicans.
    Yang YL, Lin YH, Tsao MY, Chen CG, Shih HI, Fan JC, Wang JS, Lo HJ.
    BMC Mol Biol; 2006 Jul 13; 7():22. PubMed ID: 16839415
    [Abstract] [Full Text] [Related]

  • 10. Squalene epoxidase encoded by ERG1 affects morphogenesis and drug susceptibilities of Candida albicans.
    Pasrija R, Krishnamurthy S, Prasad T, Ernst JF, Prasad R.
    J Antimicrob Chemother; 2005 Jun 13; 55(6):905-13. PubMed ID: 15845783
    [Abstract] [Full Text] [Related]

  • 11. Genome-wide expression profiling of the response to terbinafine in Candida albicans using a cDNA microarray analysis.
    Zeng YB, Qian YS, Ma L, Gu HN.
    Chin Med J (Engl); 2007 May 05; 120(9):807-13. PubMed ID: 17531123
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The Role of Ergosterol and Sphingolipids in the Localization and Activity of Candida albicans' Multidrug Transporter Cdr1p and Plasma Membrane ATPase Pma1p.
    Urbanek AK, Muraszko J, Derkacz D, Łukaszewicz M, Bernat P, Krasowska A.
    Int J Mol Sci; 2022 Sep 01; 23(17):. PubMed ID: 36077373
    [Abstract] [Full Text] [Related]

  • 15. Antimicrobial peptides enhance the candidacidal activity of antifungal drugs by promoting the efflux of ATP from Candida cells.
    Tanida T, Okamoto T, Ueta E, Yamamoto T, Osaki T.
    J Antimicrob Chemother; 2006 Jan 01; 57(1):94-103. PubMed ID: 16291868
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Tea polyphenol epigallocatechin-3-gallate inhibits ergosterol synthesis by disturbing folic acid metabolism in Candida albicans.
    Navarro-Martínez MD, García-Cánovas F, Rodríguez-López JN.
    J Antimicrob Chemother; 2006 Jun 01; 57(6):1083-92. PubMed ID: 16585130
    [Abstract] [Full Text] [Related]

  • 20. Disruption of mitochondrial function in Candida albicans leads to reduced cellular ergosterol levels and elevated growth in the presence of amphotericin B.
    Geraghty P, Kavanagh K.
    Arch Microbiol; 2003 Apr 01; 179(4):295-300. PubMed ID: 12640519
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.